NorthStar Asset Management (Pennsylvania)’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.4M Sell
47,760
-700
-1% -$35.5K 0.45% 46
2026
Q1
$2.59M Sell
48,460
-510
-1% -$29.9K 0.58% 41
2025
Q4
$3.04M Sell
48,970
-150
-0.3% -$9.26K 0.65% 34
2025
Q3
$2.95M Sell
49,120
-500
-1% -$30.6K 0.63% 35
2025
Q2
$3.11M Sell
49,620
-5,025
-9% -$302K 0.72% 33
2025
Q1
$3.29M Sell
54,645
-6,980
-11% -$434K 0.79% 32
2024
Q4
$3.6M Sell
61,625
-1,895
-3% -$113K 0.82% 28
2024
Q3
$3.76M Sell
63,520
-510
-0.8% -$29.1K 0.86% 27
2024
Q2
$3.59M Sell
64,030
-3,970
-6% -$222K 0.87% 29
2024
Q1
$3.98M Sell
68,000
-2,002
-3% -$113K 0.98% 26
2023
Q4
$3.78M Sell
70,002
-10,610
-13% -$518K 1% 21
2023
Q3
$3.91M Sell
80,612
-750
-0.9% -$39.9K 1.13% 20
2023
Q2
$4.59M Sell
81,362
-3,010
-4% -$166K 1.26% 18
2023
Q1
$4.55M Sell
84,372
-6,150
-7% -$327K 1.34% 16
2022
Q4
$4.76M Sell
90,522
-1,250
-1% -$63.4K 1.5% 15
2022
Q3
$4.33M Sell
91,772
-1,380
-1% -$71.6K 1.44% 18
2022
Q2
$4.7M Sell
93,152
-630
-0.7% -$34.3K 1.47% 17
2022
Q1
$5.72M Sell
93,782
-2,176
-2% -$130K 1.46% 17
2021
Q4
$6.32M Sell
95,958
-70
-0.1% -$4.48K 1.48% 18
2021
Q3
$6.03M Buy
96,028
+100
+0.1% +$6.38K 1.58% 18
2021
Q2
$5.77M Buy
95,928
+2,934
+3% +$170K 1.52% 19
2021
Q1
$5.12M Sell
92,994
-678
-0.7% -$37.6K 1.46% 20
2020
Q4
$5.11M Buy
93,672
+210
+0.2% +$11K 1.45% 20
2020
Q3
$4.67M Buy
93,462
+8,154
+10% +$395K 1.49% 20
2020
Q2
$3.76M Buy
85,308
+78,288
+1,115% +$3.35M 1.35% 20
2020
Q1
$264K Buy
7,020
+1,020
+17% +$42.9K 0.12% 96
2019
Q4
$264K Hold
6,000
0.1% 112
2019
Q3
$247K Hold
6,000
0.1% 111
2019
Q2
$241K Hold
6,000
0.1% 114
2019
Q1
$232K Buy
+6,000
New +$218K 0.09% 109
2018
Q4
Sell
-6,000
Closed -$227K 111
2018
Q3
$227K Hold
6,000
0.09% 110
2018
Q2
$201K Buy
+6,000
New +$195K 0.08% 109

Other funds holding IHI

NorthStar Asset Management (Pennsylvania)'s IHI Position: Q2 2026 in Review

NorthStar Asset Management (Pennsylvania) reduced its iShares US Medical Devices ETF (IHI) stake by 1.4% in Q2 2026, selling an estimated $35.5K and leaving 47,760 shares worth $2.4M. The position accounts for 0.45% of the portfolio, ranked #46.

NorthStar Asset Management (Pennsylvania) first reported a position in IHI in Q2 2018 and has held it in 32 quarters since. The position peaked at $6.32M in Q4 2021. 193 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • NorthStar Asset Management (Pennsylvania) held 47,760 shares of iShares US Medical Devices ETF worth $2.4M as of Q2 2026.
  • NorthStar Asset Management (Pennsylvania) sold 700 iShares US Medical Devices ETF shares in Q2 2026, an estimated $35.5K.
  • iShares US Medical Devices ETF made up 0.45% of NorthStar Asset Management (Pennsylvania)'s portfolio in Q2 2026, its #46 holding.
  • NorthStar Asset Management (Pennsylvania) first reported a position in iShares US Medical Devices ETF in Q2 2018 and has held it in 32 quarters since.
  • NorthStar Asset Management (Pennsylvania)'s iShares US Medical Devices ETF position peaked at $6.32M in Q4 2021.
  • 193 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on NorthStar Asset Management (Pennsylvania)'s 13F filing for Q2 2026, filed 27 Jul 2026.